|
Total properties:
14
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/17/2020
|
Application #:
|
14518346
|
Filing Dt:
|
10/20/2014
|
|
Publication #:
|
|
Pub Dt:
|
02/05/2015
| | | | |
|
Title:
|
Extended Dicer Substrate Agents and Methods for the Specific Inhibition of Gene Expression
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/22/2020
|
Application #:
|
14518379
|
Filing Dt:
|
10/20/2014
|
|
Publication #:
|
|
Pub Dt:
|
02/05/2015
| | | | |
|
Title:
|
Extended Dicer Substrate Agents and Methods for the Specific Inhibition of Gene Expression
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
15621395
|
Filing Dt:
|
06/13/2017
|
|
Publication #:
|
|
Pub Dt:
|
10/26/2017
| | | | |
|
Title:
|
Ligand-Modified Double-Stranded Nucleic Acids
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/25/2020
|
Application #:
|
15800440
|
Filing Dt:
|
11/01/2017
|
|
Publication #:
|
|
Pub Dt:
|
02/15/2018
| | | | |
|
Title:
|
METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF KRAS BY ASYMMETRIC DOUBLE-STRANDED RNA
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/03/2020
|
Application #:
|
16084852
|
Filing Dt:
|
09/13/2018
|
|
Publication #:
|
|
Pub Dt:
|
03/07/2019
| | | | |
|
Title:
|
COMPOSITIONS AND METHODS FOR THE TREATMENT OF A BETA-CATENIN-ASSOCIATED DISEASE OR DISORDER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/07/2022
|
Application #:
|
16165760
|
Filing Dt:
|
10/19/2018
|
|
Publication #:
|
|
Pub Dt:
|
05/23/2019
| | | | |
|
Title:
|
PROCESS FOR FORMULATING AN ANIONIC AGENT
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/13/2021
|
Application #:
|
16204053
|
Filing Dt:
|
11/29/2018
|
|
Publication #:
|
|
Pub Dt:
|
03/21/2019
| | | | |
|
Title:
|
AMINE CATIONIC LIPIDS AND USES THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/19/2022
|
Application #:
|
16325979
|
Filing Dt:
|
02/15/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/13/2019
| | | | |
|
Title:
|
COMPOSITIONS COMPRISING REVERSIBLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/16/2022
|
Application #:
|
16328546
|
Filing Dt:
|
02/26/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/13/2019
| | | | |
|
Title:
|
4'-PHOSPHATE ANALOGS AND OLIGONUCLEOTIDES COMPRISING THE SAME
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/16/2024
|
Application #:
|
16381931
|
Filing Dt:
|
04/11/2019
|
|
Publication #:
|
|
Pub Dt:
|
10/17/2019
| | | | |
|
Title:
|
DOUBLE-STRANDED NUCLEIC ACID INHIBITOR MOLECULES MODIFIED WITH TM-INCREASING NUCLEOTIDES
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/07/2023
|
Application #:
|
16497310
|
Filing Dt:
|
09/24/2019
|
|
Publication #:
|
|
Pub Dt:
|
12/03/2020
| | | | |
|
Title:
|
REDUCING BETA-CATENIN EXPRESSION TO POTENTIATE IMMUNOTHERAPY
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16555193
|
Filing Dt:
|
08/29/2019
|
|
Publication #:
|
|
Pub Dt:
|
01/30/2020
| | | | |
|
Title:
|
LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/18/2021
|
Application #:
|
16754452
|
Filing Dt:
|
04/08/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/27/2020
| | |
PCT #:
|
US2018056317
|
|
Title:
|
BETA CATENIN NUCLEIC ACID INHIBITOR MOLECULE
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/14/2023
|
Application #:
|
16958969
|
Filing Dt:
|
06/29/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/29/2020
| | |
PCT #:
|
US2019012193
|
|
Title:
|
REDUCING BETA-CATENIN AND IDO EXPRESSION TO POTENTIATE IMMUNOTHERAPY
|
|
